BiondVax Pharmaceuticals Ltd. – NASDAQ:BVXV

Financial Health
0
1
2
3
4
5
6
7
8
9

BiondVax Pharmaceuticals Ltd. stock price monthly change

-1.45%
month

BiondVax Pharmaceuticals Ltd. stock price quarterly change

-25.27%
quarter

BiondVax Pharmaceuticals Ltd. stock price yearly change

+32.55%
year

BiondVax Pharmaceuticals Ltd. key metrics

Market Cap
4.96M
Enterprise value
35.86M
P/E
-0.4
EV/Sales
N/A
EV/EBITDA
-2.59
Price/Sales
N/A
Price/Book
1.16
PEG ratio
-0.05
EPS
N/A
Revenue
N/A
EBITDA
-5.00M
Income
7.78M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BiondVax Pharmaceuticals Ltd. stock price history

BiondVax Pharmaceuticals Ltd. stock forecast

BiondVax Pharmaceuticals Ltd. financial statements

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Profit margin
Sep 2022 0 9.79M
Dec 2022 0 5.59M
Mar 2023 2.01M -3.84M -190.67%
Jun 2023 0 -3.76M
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Earnings per share (EPS)
2022-06-01 -4 -2
2022-08-25 -0.40005 -2.1
2022-11-30 -0.006 0.06
2023-04-17 -0.3 -0.3
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Debt to assets
Sep 2022 74717000 65.35M 87.47%
Dec 2022 27067000 28.82M 106.5%
Mar 2023 23292000 28.10M 120.65%
Jun 2023 19897000 27.00M 135.74%
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Cash Flow
Jun 2022 -10.40M -84K -468K
Dec 2022 15.85M -483K -25.80M
Mar 2023 -3.05M -6K 0
Jun 2023 -2.87M -377K 0

BiondVax Pharmaceuticals Ltd. alternative data

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Employee count
Aug 2023 33
Sep 2023 33
Oct 2023 33
Nov 2023 33
Dec 2023 33
Jan 2024 33
Feb 2024 33
Mar 2024 33
Apr 2024 33
May 2024 33
Jun 2024 33
Jul 2024 33

BiondVax Pharmaceuticals Ltd. other data

0.00% -0.32%
of BVXV is owned by hedge funds
16.48K -225.56K
shares is hold by hedge funds
Wednesday, 6 September 2023
globenewswire.com
Friday, 11 August 2023
globenewswire.com
Tuesday, 1 August 2023
globenewswire.com
Thursday, 16 March 2023
GlobeNewsWire
Thursday, 2 February 2023
GlobeNewsWire
Monday, 23 January 2023
PennyStocks
Monday, 21 November 2022
PRNewsWire
Thursday, 3 November 2022
PRNewsWire
Tuesday, 18 October 2022
Newsfile Corp
Tuesday, 11 October 2022
PRNewsWire
Thursday, 8 September 2022
PRNewsWire
Monday, 9 May 2022
PRNewsWire
Monday, 4 April 2022
Seeking Alpha
Thursday, 24 March 2022
InvestorPlace
Benzinga
PennyStocks
Tuesday, 22 February 2022
PRNewsWire
Tuesday, 15 February 2022
PRNewsWire
Wednesday, 26 January 2022
PRNewsWire
Tuesday, 28 December 2021
PennyStocks
Pulse2
Wednesday, 22 December 2021
InvestorPlace
PennyStocks
Pulse2
Tuesday, 30 November 2021
Pulse2
Monday, 15 November 2021
PRNewsWire
Tuesday, 19 October 2021
PRNewsWire
Thursday, 26 August 2021
PRNewsWire
  • When is BiondVax Pharmaceuticals Ltd.'s next earnings date?

    Unfortunately, BiondVax Pharmaceuticals Ltd.'s (BVXV) next earnings date is currently unknown.

  • Does BiondVax Pharmaceuticals Ltd. pay dividends?

    No, BiondVax Pharmaceuticals Ltd. does not pay dividends.

  • How much money does BiondVax Pharmaceuticals Ltd. make?

    BiondVax Pharmaceuticals Ltd. has a market capitalization of 4.96M. BiondVax Pharmaceuticals Ltd. made a loss 531K US dollars in net income (profit) last year or -$0.3 on an earnings per share basis.

  • What is BiondVax Pharmaceuticals Ltd.'s stock symbol?

    BiondVax Pharmaceuticals Ltd. is traded on the NASDAQ under the ticker symbol "BVXV".

  • What is BiondVax Pharmaceuticals Ltd.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of BiondVax Pharmaceuticals Ltd.?

    Shares of BiondVax Pharmaceuticals Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does BiondVax Pharmaceuticals Ltd. have?

    As Jul 2024, BiondVax Pharmaceuticals Ltd. employs 33 workers.

  • When BiondVax Pharmaceuticals Ltd. went public?

    BiondVax Pharmaceuticals Ltd. is publicly traded company for more then 10 years since IPO on 12 May 2015.

  • What is BiondVax Pharmaceuticals Ltd.'s official website?

    The official website for BiondVax Pharmaceuticals Ltd. is biondvax.com.

  • How can i contact BiondVax Pharmaceuticals Ltd.?

    BiondVax Pharmaceuticals Ltd. can be reached via phone at +972 8 930 2529.

BiondVax Pharmaceuticals Ltd. company profile:

BiondVax Pharmaceuticals Ltd.

biondvax.com
Exchange:

NASDAQ

Full time employees:

33

Industry:

Biotechnology

Sector:

Healthcare

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Jerusalem BioPark Building
Jerusalem,

CIK: 0001611747
ISIN: US09073Q1058
CUSIP: 09073Q105